Severe or persistent vomiting Signs of dehydration (excessive thirst, dark urine, dizziness) Severe abdominal pain Any symptoms of pancreatitis (pain radiating to your back, fever) Significant changes in bowel habits lasting more than a few days GLP-1 Medications in 2026: Whats New The GLP-1 landscape has expanded significantly entering 2026, offering patients more options and broader access than ever before
Exploring GLP-1 Production A Look Inside the Semaglutide Purification Process Recently, Ive been diving deep into the production process of GLP-1 drugs like Semaglutide, which play an increasingly critical role in metabolic disease treatment
Figure 2 3.1 Physicochemical protection mechanisms Nanoencapsulation of nutraceuticals (vitamins, polyphenols, carotenoids, omega-3 s, etc.) has been widely shown to enhance their physicochemical stability and shelf-life
It exceeds many GLP-1 therapies that have been on the market for years
For TTC or pregnant individuals, add fetal monitoring and obstetrician consultation
No significant sex- or weight-based risks were noted for liraglutide or tirzepatide